文献速递流行病学与生物统计组学、生物样本库与精准医学基础与转化研究

SARS-CoV-2监测的下一阶段:实时分子流行病学

The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology.
PubMed 文献 · Nat Med · 2021-09-09

但基因型到表型的预测无法跟上测序速度,需系统方法连接全球基因组监测与变异株表型特征的及时评估。

要点

  • 实时基因组监测已为公共卫生决策提供依据,并识别可能影响病毒特性和干预效果的突变。
  • 基因型到表型的快速预测尚不可行,需建立系统评估新变异株表型特征的路径。
  • 下一阶段应连接全球基因组监测与及时表型评估,支持诊断、疫苗、治疗及非药物干预的更新。

核心结论

  • 需建立系统方法连接全球基因组监测与及时的新变异株表型评估,以应对大流行下一阶段。

研究设计与样本

  • 综述,总结关于关键病毒突变和变异株的现有知识,并展望演变大流行的下一阶段监测。

主要发现

  • 基因组资源在疫情期间为公共卫生决策提供信息,并检测到可能影响毒力、致病性、宿主范围、免疫逃逸及诊断和治疗效果的突变。
  • 基因型到表型预测无法以基因组测序的快速节奏进行。

临床怎么用

  • 利用实时基因组监测识别可能影响诊断、疫苗、治疗及非药物干预效果的新变异株。
  • 将基因组监测与及时的表型评估系统连接,以支持诊断、疫苗和治疗的开发与更新。

局限性

  • 基因型到表型预测不能以基因组测序的快速节奏进行。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The current coronavirus disease 2019 (COVID-19) pandemic is the first to apply whole-genome sequencing near to real time, with over 2 million severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) whole-genome sequences generated and shared through the GISAID platform. This genomic resource informed public health decision-making throughout the pandemic; it also allowed detection of mutations that might affect virulence, pathogenesis, host range or immune escape as well as the effectiveness of SARS-CoV-2 diagnostics and therapeutics. However, genotype-to-phenotype predictions cannot be performed at the rapid pace of genomic sequencing. To prepare for the next phase of the pandemic, a systematic approach is needed to link global genomic surveillance and timely assessment of the phenotypic characteristics of novel variants, which will support the development and updating of diagnostics, vaccines, therapeutics and nonpharmaceutical interventions. This Review summarizes the current knowledge on key viral mutations and variants and looks to the next phase of surveillance of the evolving pandemic.

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Oude Munnink BB, Worp N, Nieuwenhuijse DF, et al. The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology. Nat Med. 2021. PMID: 34504335. doi:10.1038/s41591-021-01472-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。